Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic's Disease) and Multiple Sclerosis-A Review

被引:20
作者
Maciak, Karina [1 ]
Pietrasik, Sylwia [1 ]
Dziedzic, Angela [1 ]
Redlicka, Justyna [2 ]
Saluk-Bijak, Joanna [1 ]
Bijak, Michal [3 ]
Wlodarczyk, Tomasz [4 ]
Miller, Elzbieta [2 ]
机构
[1] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, PL-90236 Lodz, Poland
[2] Med Univ Lodz, Dept Neurol Rehabil, PL-93113 Lodz, Poland
[3] Univ Lodz, Fac Biol & Environm Protect, Biohazard Prevent Ctr, PL-90236 Lodz, Poland
[4] Dr Charles Jonscher Hosp Lodz, Dept Ophthalmol, Third Municipal Hosp, PL-93113 Lodz, Poland
关键词
neuromyelitis optica; Devic's disease; multiple sclerosis; biomarkers; Th17-related cytokines; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLONY-STIMULATING FACTOR; PLASMA OSTEOPONTIN LEVELS; CD4(+) T-CELLS; TH17; CELLS; CLINICAL-COURSE; AQUAPORIN; G-CSF; DIAGNOSTIC-CRITERIA; SPECTRUM DISORDER;
D O I
10.3390/ijms22168946
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multiple sclerosis (MS) and Devic's disease (NMO; neuromyelitis optica) are autoimmune, inflammatory diseases of the central nervous system (CNS), the etiology of which remains unclear. It is a serious limitation in the treatment of these diseases. The resemblance of the clinical pictures of these two conditions generates a partial possibility of introducing similar treatment, but on the other hand, a high risk of misdiagnosis. Therefore, a better understanding and comparative characterization of the immunopathogenic mechanisms of each of these diseases are essential to improve their discriminatory diagnosis and more effective treatment. In this review, special attention is given to Th17 cells and Th17-related cytokines in the context of their potential usefulness as discriminatory markers for MS and NMO. The discussed results emphasize the role of Th17 immune response in both MS and NMO pathogenesis, which, however, cannot be considered without taking into account the broader perspective of immune response mechanisms.
引用
收藏
页数:19
相关论文
共 151 条
  • [1] Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
    Agasing, Agnieshka M.
    Wu, Qi
    Khatri, Bhuwan
    Borisow, Nadja
    Ruprecht, Klemens
    Brandt, Alexander Ulrich
    Gawde, Saurabh
    Kumar, Gaurav
    Quinn, James L.
    Ko, Rose M.
    Mao-Draayer, Yang
    Lessard, Christopher J.
    Paul, Friedemann
    Axtell, Robert C.
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [2] Alonso Veronica R., 2018, Central Nervous System Agents in Medicinal Chemistry, V18, P4, DOI 10.2174/1871524916666160229115047
  • [3] RETRACTED: Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies (Retracted article. See vol. 17, 2016)
    Amedei, Amedeo
    Prisco, Domenico
    D'Elios, Mario Milco
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (10) : 13438 - 13460
  • [4] Race and ethnicity on MS presentation and disease course
    Amezcua, Lilyana
    McCauley, Jacob L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (05) : 561 - 567
  • [5] Phenotypic and functional features of human Th17 cells
    Annunziato, Francesco
    Cosmi, Lorenzo
    Santarlasci, Veronica
    Maggi, Laura
    Liotta, Francesco
    Mazzinghi, Benedetta
    Parente, Eliana
    Fili, Lucia
    Ferri, Simona
    Frosali, Francesca
    Giudici, Francesco
    Romagnani, Paola
    Parronchi, Paola
    Tonelli, Francesco
    Maggi, Enrico
    Romagnani, Sergio
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) : 1849 - 1861
  • [6] Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
    Arellano, Gabriel
    Acuna, Eric
    Reyes, Lilian I.
    Ottum, Payton A.
    De Sarno, Patrizia
    Villarroel, Luis
    Ciampi, Ethel
    Uribe-San Martin, Reinaldo
    Carcamo, Claudia
    Naves, Rodrigo
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [7] The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels
    Babaloo, Zohreh
    AIiparasti, Mohammad Reza
    Babaiea, Farhad
    Almasi, Shohreh
    Baradaran, Behzad
    Farhoudi, Mehdi
    [J]. IMMUNOLOGY LETTERS, 2015, 164 (02) : 76 - 80
  • [8] Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase
    Barros, P. O.
    Cassano, T.
    Hygino, J.
    Ferreira, T. B.
    Centuriao, N.
    Kasahara, T. M.
    Andrade, R. M.
    Linhares, U. C.
    Andrade, A. F. B.
    Vasconcelos, C. C. F.
    Alvarenga, R.
    Marignier, R.
    Bento, C. A. M.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 183 (03) : 480 - 489
  • [9] IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
    Bassi, Mario Stampanoni
    Iezzi, Ennio
    Drulovic, Jelena
    Pekmezovic, Tatjana
    Gilio, Luana
    Furlan, Roberto
    Finardi, Annamaria
    Marfia, Girolama Alessandra
    Sica, Francesco
    Centonze, Diego
    Buttari, Fabio
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [10] Therapeutic Management of Severe Relapses in Multiple Sclerosis
    Bevan, Carolyn
    Gelfand, Jeffrey M.
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2015, 17 (04) : 1 - 14